← Back to headlines





Friedreich’s Ataxia Patients Plead for HSE Drug Funding
Patients suffering from Friedreich’s Ataxia are urging the HSE to fund a potentially life-changing treatment that costs €288,000 per patient annually, which the HSE has resisted funding.
20 Aug, 16:39 — 20 Aug, 16:39
Sources
Showing 1 of 1 sources
Related Stories

Lionel Richie Hospitalized in ICU Following St. Louis Concert
1h ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
6h ago

Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
8h ago

England Pharmacies to Offer Free Quick Cholesterol Screening Tests
16h ago